Histone Deacetylase Inhibitors: Clinical Implications for Hematological Malignancies

Clinical Epigenetics - Germany
doi 10.1007/s13148-010-0006-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Inhibitors of Histone-Deacetylase

Journal of Applied Biomedicine
GeneticsMolecular BiologyPharmacologyBiochemistryBiological SciencesToxicologyMedicineAgriculturalNeurosciencePharmaceutics
2005English

Pharmacogenomics and Histone Deacetylase Inhibitors

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2016English

Histone Deacetylase Inhibitors From Burkholderia Thailandensis

Journal of Natural Products
Organic ChemistryMolecular MedicinePharmacologyComplementaryPharmaceutical ScienceAnalytical ChemistryAlternative MedicineDrug Discovery
2011English

Histone Deacetylase Inhibitors as Cancer Therapeutics

Annals of Translational Medicine
Medicine
2016English

Histone Deacetylase Inhibitors in Cancer Therapy

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Histone Deacetylase Inhibitors in Multiple Myeloma

Hematology Reports
Hematology
2009English

Discovery of Histone Deacetylase 8 Selective Inhibitors

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2011English

Histone Deacetylase Inhibitors Preserve Function in Aging Axons

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2012English

Development of Histone Deacetylase Inhibitors as Therapeutics for Neurological Disease

Future Neurology
Neurology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy